Post Covid Syndrome: Clinical Pattern and Functional Assessment

Covid19 Clinical Trial

Official title:

Post Covid Syndrome: Clinical Pattern and Functional Assessment

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04561141
• Other study ID #: postcovid syndrome
• Status: Not yet recruiting
• Start date: December 1, 2020
• Est. completion date: January 1, 2022

Study information

• Verified date: September 2020
• Source: Assiut University
• Contact: Mostafa Mahmoud
• Phone: 0101 212 4598
• Email: mostafamahmoud826[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Aim(s) of the Research :

1. Identify post covid symptoms

2. prevalance of post covid syndrome among survivours

Description:

There is currently very limited information on the nature and prevalence of post-COVID-19 symptoms after hospital discharge. On 11th March 2020, corona virus disease 2019 (COVID-19) was declared a global pandemic by the World Health Organisation (WHO). Egypt has been one of the worst affected countries with over 101,500 confirmed cases and more than 5,696 confirmed deaths at the time of writing (17/9 2020) .1 COVID-19 is caused by the corona virus SARSCoV-2 and presents with a wide spectrum of clinical symptoms. Wu et al reported that 81% of people with COVID-19 in China presented with mild symptoms; 14% presented with symptoms of severe respiratory dysfunction; and 5% developed a critical illness with respiratory failure, septic shock, and multiple organ dysfunction or failure.2 The medium and long-term problems experienced by survivors of COVID-19 after discharge from hospital are currently unknown, but there is some emerging evidence. An Italian study followed-up 143 individuals 7 weeks post-discharge and found 53% reporting fatigue, 43% breathlessness and 27% joint pain.3 Post-discharge symptoms may also be predicted from the previous coronavirus outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2002 and Middle East Respiratory Syndrome (MERS) in 2012. A meta-analysis of 28 follow-up studies found that one quarter of hospitalised survivors of SARS and MERS had reduced lung function and exercise capacity at six months post-discharge.4 At one year, post-traumatic stress disorder (PTSD), depression and anxiety, and reduced quality of life were observed Specific data concerning the rehabilitation needs of this group is therefore urgently required.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 85
• Est. completion date: January 1, 2022
• Est. primary completion date: December 1, 2021
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. patients diagnosed as covid 19 with chest ct and/or nasopharyngeal swab for covid 19

2. age 18 years old and above

3. post covid syndrome after 6 weeks

Exclusion Criteria:

• 1-below age of 18 2 -not confirmed cases 3. symptoms less than 6 weeks

Related Conditions & MeSH terms

• Covid19

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Identify post covid symptoms	by interview questionnaire	after 4 weeks of diagnosis
Secondary	prevalance of post covid syndrome among survivours	by interview questionnaire	after 4 weeks of diagnosis

External Links

•   Related Info